Covaxin booster can neutralise Omicron: Bharat Biotech

12-01-2022 Wed 19:49 IST | IANS | Health
Covaxin booster can neutralise Omicron: Bharat Biotech

New Delhi, Jan 12: Covaxin's booster dose is able to neutralise the vaccine evading Omicron variant of Covid-19, according to a study conducted at US' Emory University, Bharat Biotech announced on Wednesday.

Earlier studies have demonstrated the neutralising potential of Covaxin against other SARS-CoV-2 variants of concern such as Alpha, Beta, Delta, Zeta, and Kappa, it said.

The new study demonstrated "sera from subjects who received a booster dose of Covaxin (BBV152) six months after getting a primary two-dose series of Covaxin (BBV152), neutralised the SARS-CoV-2 Omicron and Delta variants", the Hyderabad-based drug maker said in a statement.

The company said that the neutralisation activity seen among people boosted with Covaxin was comparable to what has been observed in mRNA vaccine-boosted people against the Omicron variant.

More than 90 per cent of all individuals boosted with Covaxin showed neutralising antibodies. All participants received an initial two-dose schedule of Covaxin at Day 0 and Day 28. The study findings will soon be posted on preprint server medrxiv, the company said.

"Data from this preliminary analysis show individuals receiving a booster dose of Covaxin have a significant immune response to both the Omicron and Delta variants. These findings suggest that a booster dose has the potential to reduce disease severity and hospitalisations," said Mehul Suthar, Assistant Professor, Emory Vaccine Center and who led the laboratory analysis, in the statement.

Formulated uniquely such that the same dosage can be administered to adults and children alike, Covaxin is a ready-to-use, liquid vaccine, stored at 2 - 8 degrees Celsius, with 12 months shelf life and multi-dose vial policy, Bharat Biotech said.

In the wake of Omicron, many countries have rolled out third booster doses to tackle the rising infections. India has also started a "precautionary dose" for health workers and the elderly from January 10.

More News
Naidu to chair meeting of RS floor leaders ahead of Budget Session
26 minutes ago
Real estate sector pins hope on Budget FY23 to sustain growth momentum
27 minutes ago
Deepak Hooda has gone through a tough period, says Irfan Pathan
31 minutes ago
Lyrical video of 'Thozhi' from Dulquer-starrer 'Hey Sinamika' released
32 minutes ago
Air India comes with over 140 aircraft but no real estate assets for Tata Sons
36 minutes ago
BCCI explore ways to restart domestic cricket season
41 minutes ago
Centre clarifies on eligible age for vaccines for 15-18 group
44 minutes ago
'Time to look ahead, journey starts now': Tata Group Chairman tells AI staff
1 hour ago
Indian Army thanks Chinese PLA for handing over Arunachal youth
1 hour ago
Telangana urges Centre to bring MNREGS-like scheme for urban poor
1 hour ago
Centre extends Covid-19 guidelines till Feb 28
2 hours ago
ED attaches assets worth Rs 3.19 cr of Hyderabad firm officials
3 hours ago
Maha: Now, wine permitted to be sold in supermarkets
3 hours ago
Kudos to Nani, Shyam Singa Roy achieves a rare feat on Netflix
3 hours ago
With Air India on-board Tatas emerge as major aviation players; plans to pilot synergies between airlines
3 hours ago
Cong MLC Jeevan Reddy fires a salvo at KCR on Kaleshwaram project
4 hours ago
TDP breaks silence on Jagan govt's move to create NTR district
4 hours ago
Nandamuri Balakrishna welcomes formation of new districts in AP
4 hours ago
Nagarjuna refutes rumours on Samantha-Naga Chaitanya divorce
4 hours ago
Even minor accident due to drunken driving should not be treated leniently: SC
5 hours ago